Medawar Building for Pathogen Research
In research, Medawar Building for Pathogen Research stands highest in Life Sciences (#2,171 of 14,347 worldwide), over all time.
- World rank, all time
- #5,625 of 42,892
- Rank in United Kingdom
- #352 of 2,253
- Research works
- 247 ▲ 77% vs 2013–17
- Citations
- 20k 82.7 per fractional work
- Top-10% rate
- 35.2% record average 16.5%
- Open access
- 76% world 28%
What is Medawar Building for Pathogen Research known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #2,171 of 14,347 | 43.6% | 129 |
Each strip is that field’s whole ranked pool, with the notch where Medawar Building for Pathogen Research sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 21.2×. Every wedge is a field page.
- Immunology and Microbiology 21.2×
- Veterinary 3.5×
- Biochemistry, Genetics and Molecular Biology 3.4×
- Medicine 2.2×
- Agricultural and Biological Sciences 1.4×
- Neuroscience 1.1×
- Health Professions 1.0×
- Mathematics 0.9×
- Chemistry 0.4×
- Physics and Astronomy 0.3×
- Economics, Econometrics and Finance 0.3×
- Decision Sciences 0.3×
- Environmental Science 0.2×
- Nursing 0.2×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Psychology 0.2×
- Social Sciences 0.2×
- Arts and Humanities 0.1×
- Computer Science 0.0×
Which keywords describe research at Medawar Building for Pathogen Research?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Vaccine, Immune Response, Immunity, SARS-CoV-2, Pandemic, ACE2 Receptor and Pathogenesis.
- Vector Control
- AIDS
- Inflammation
- Genetic Variation
- Autoimmunity
- Innate Immunity
- Cancer
- Vaccine Development
- Antiviral Therapy
- antibody
- Drug Resistance
- Viral Transmission
- Natural Killer Cells
- Coronavirus
- Pathogenesis
- SARS-CoV-2
- Immunity
- Vaccine
- Epidemiology
- Immune Response
- Pandemic
- ACE2 Receptor
- Treatment
- NK Cell Recognition
- Antiretroviral Therapy
- Cancer Immunotherapy
- Mutation
- spike protein
- Liver Disease
- Antigen Presentation
- Infection
- Antibodies
- Foxp3
- Hepatocellular Carcinoma
- TGF-ß
- HIV
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 36 words, with their numbers
- Epidemiology8▲ 5.5×38 topics
- Vaccine5▲ 32×9 topics
- Immune Response4▲ 21×10 topics
- Immunity3▲ 22×5 topics
- Pandemic3▲ 7.3×5 topics
- SARS-CoV-23▲ 24×5 topics
- ACE2 Receptor3▲ 29×2 topics
- Pathogenesis2▲ 13×12 topics
- Treatment2▲ 5.5×12 topics
- Coronavirus2▲ 31×2 topics
- NK Cell Recognition2▲ 92×1 topic
- Natural Killer Cells2▲ 92×1 topic
- Antiretroviral Therapy2▲ 36×5 topics
- Viral Transmission2▲ 40×3 topics
- Cancer Immunotherapy2▲ 33×3 topics
- Drug Resistance2▲ 18×5 topics
- Mutation2▲ 27×2 topics
- antibody2▲ 47×1 topic
- spike protein2▲ 47×1 topic
- Antiviral Therapy2▲ 50×3 topics
- Liver Disease2▲ 44×3 topics
- Vaccine Development2▲ 16×8 topics
- Antigen Presentation1▲ 39×2 topics
- Cancer1▲ 2.5×13 topics
- Infection1▲ 14×4 topics
- Innate Immunity1▲ 11×5 topics
- Antibodies1▲ 59×2 topics
- Autoimmunity1▲ 24×4 topics
- Foxp31▲ 85×1 topic
- Genetic Variation1▲ 14×2 topics
- Hepatocellular Carcinoma1▲ 14×3 topics
- Inflammation1▲ 1.46×9 topics
- TGF-ß1▲ 19×1 topic
- AIDS1▲ 108×1 topic
- HIV1▲ 32×1 topic
- Vector Control1▲ 24×3 topics
Which research topics does Medawar Building for Pathogen Research publish most on?
By volume in 2022–2025: Immune Cell Function and Interaction, SARS-CoV-2 and COVID-19 Research, T-cell and B-cell Immunology and HIV Research and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune Cell Function and Interaction Immunology 2 works
- 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
- 3 T-cell and B-cell Immunology Immunology 1 works
- 4 HIV Research and Treatment Virology 1 works
- 5 Hepatitis C virus research Hepatology 1 works
- 6 Viral gastroenteritis research and epidemiology Infectious Diseases 1 works
- 7 COVID-19 Clinical Research Studies Infectious Diseases 1 works
- 8 Immunotherapy and Immune Responses Immunology 1 works
- 9 Trypanosoma species research and implications Epidemiology 1 works
- 10 HIV/AIDS drug development and treatment Infectious Diseases 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Medawar Building for Pathogen Research's research output changed?
Output in 2018–2022 was 77% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Oxford
- University of Oxford
- John Radcliffe Hospital
- Science Oxford
- Oxford Brookes University
- Nuffield Orthopaedic Centre
- Oxford University Hospitals NHS Trust
- Churchill Hospital
- Oxford University Press (United Kingdom)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.